Y Intercept Hong Kong Ltd Sells 136 Shares of Teleflex Incorporated (NYSE:TFX)

Y Intercept Hong Kong Ltd decreased its position in shares of Teleflex Incorporated (NYSE:TFX) by 3.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,179 shares of the medical technology company’s stock after selling 136 shares during the period. Y Intercept Hong Kong Ltd’s holdings in Teleflex were worth $1,034,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also added to or reduced their stakes in TFX. XTX Topco Ltd boosted its holdings in shares of Teleflex by 398.8% in the 3rd quarter. XTX Topco Ltd now owns 5,422 shares of the medical technology company’s stock valued at $1,341,000 after purchasing an additional 4,335 shares in the last quarter. iSAM Funds UK Ltd acquired a new stake in Teleflex in the third quarter valued at about $397,000. Wahed Invest LLC grew its position in Teleflex by 15.8% in the third quarter. Wahed Invest LLC now owns 1,142 shares of the medical technology company’s stock valued at $282,000 after acquiring an additional 156 shares during the last quarter. State Street Corp raised its stake in Teleflex by 1.0% during the third quarter. State Street Corp now owns 2,057,080 shares of the medical technology company’s stock worth $508,757,000 after acquiring an additional 21,291 shares in the last quarter. Finally, Quarry LP lifted its holdings in shares of Teleflex by 71.5% in the third quarter. Quarry LP now owns 391 shares of the medical technology company’s stock worth $97,000 after acquiring an additional 163 shares during the last quarter. 95.62% of the stock is owned by institutional investors.

Teleflex Stock Down 0.2 %

Shares of NYSE:TFX opened at $183.31 on Friday. The firm has a market cap of $8.51 billion, a P/E ratio of 36.44, a P/E/G ratio of 1.88 and a beta of 1.16. Teleflex Incorporated has a 12-month low of $182.80 and a 12-month high of $257.85. The business has a fifty day simple moving average of $210.58 and a 200 day simple moving average of $220.93. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37.

Teleflex (NYSE:TFX) last issued its quarterly earnings results on Thursday, October 31st. The medical technology company reported $3.49 earnings per share for the quarter, beating the consensus estimate of $3.38 by $0.11. The company had revenue of $764.40 million during the quarter, compared to analysts’ expectations of $768.68 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The business’s quarterly revenue was up 2.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $3.64 earnings per share. Analysts predict that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Friday, November 15th will be given a $0.34 dividend. The ex-dividend date is Friday, November 15th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.74%. Teleflex’s dividend payout ratio (DPR) is currently 27.04%.

Wall Street Analyst Weigh In

TFX has been the topic of several research reports. Mizuho decreased their price target on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating on the stock in a report on Friday, November 1st. Needham & Company LLC reaffirmed a “hold” rating on shares of Teleflex in a research note on Friday, November 1st. Royal Bank of Canada dropped their price target on Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a research note on Friday, November 1st. StockNews.com upgraded Teleflex from a “hold” rating to a “buy” rating in a research report on Thursday, November 28th. Finally, Truist Financial reiterated a “hold” rating and issued a $227.00 target price (down from $255.00) on shares of Teleflex in a research report on Monday, November 4th. Three equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $259.00.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.